← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Amprion, Inc.
San Francisco, CA
$8,734,506
Total funding
5
Grants
Funding over time
peak $1.8M · FY2012–22$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$8,734,506 · 5
By mechanism
R42$3,961,322 · 3
SB1$2,468,398 · 1
U44$2,304,786 · 1
Investigators at Amprion, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease$1,254,529
SB1 · FY2016 · NS
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease$1,213,869
SB1 · FY2017 · NS
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease$809,593
U44 · FY2022 · NS
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease$809,593
U44 · FY2021 · NS
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease$685,600
U44 · FY2020 · NS
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease$663,017
R42 · FY2019 · AG
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease$618,037
R42 · FY2020 · AG
Blood-based diagnostics for Alzheimer's Disease$509,989
R42 · FY2016 · AG
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease$502,343
R42 · FY2013 · NS
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease$501,426
R42 · FY2014 · NS
Blood-based diagnostics for Alzheimer's Disease$495,066
R42 · FY2017 · AG
Blood-based diagnostics for Alzheimer's Disease$223,574
R42 · FY2015 · AG
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease$217,647
R42 · FY2018 · AG
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease$165,543
R42 · FY2012 · NS
Blood-based diagnostics for Alzheimer's Disease$64,680
R42 · FY2016 · AG